Cytotoxically Impaired Transplant Recipients Can Efficiently Resist Major Histocompatibility Complex-Matched Bone Marrow Allografts

Monica Jones, Masanobu Komatsu, Robert B. Levy

Research output: Contribution to journalArticle

Abstract

High rates of allograft rejecrion using T cell-depleted marrow or after transplantations into multiply transfused recipients have been reported. Together with current approaches to diminish host preparative immunosuppression before stem cell transplant, issues regarding the cells and effector pathways involved in resistance to progenitor cell presence in recipients are of increasing interest. The present investigation addressed questions concerning the contribution of cytotoxic effector mechanisms used by host cells involved in resistance to progenitor cell engraftment. A murine model was developed in which short-term resistance against major histocompatibility complex (MHC)-matched allogeneic T cell-depleted marrow was examined using a sensitive in vitro assay to detect progenitor cell presence by colony formation in vitro. Resistance was found to be dependent on previous priming to donor non-MHC antigens and could be transferred by a CD3+NK1.1- population. The resistance mechanism explicitly discriminated between donor and syngeneic progenitors after mixed marrow transplantation. Interestingly, the resistance was not impaired in animals unable to mediate cell-mediated cytotoxicity involving perforin-dependent or CD95L-dependent pathways. These results indicate that either cytotoxic effector pathway alone is sufficient to effect marrow allograft resistance or that non-perforin and CD95L effector mechanisms are responsible for barrier activity. The findings are discussed with respect to previous studies concerning T-cell involvement in resistance to MHC-and hematopoietic histoincompatible-mismatched marrow grafts.

Original languageEnglish (US)
Pages (from-to)456-464
Number of pages9
JournalBiology of Blood and Marrow Transplantation
Volume6
Issue number4 A
DOIs
StatePublished - Jan 1 2000
Externally publishedYes

Fingerprint

Major Histocompatibility Complex
Allografts
Bone Marrow
Stem Cells
Fas Ligand Protein
T-Lymphocytes
Transplantation
Tissue Donors
Transplants
Perforin
Histocompatibility Antigens
Immunosuppression
Transplant Recipients
Population
In Vitro Techniques

Keywords

  • CD95L-defective
  • Cytotoxic impairment
  • Marrow graft resistance
  • Minor histocompatibility antigen
  • Perforin-deficient
  • T-cell depletion

ASJC Scopus subject areas

  • Hematology
  • Transplantation

Cite this

Cytotoxically Impaired Transplant Recipients Can Efficiently Resist Major Histocompatibility Complex-Matched Bone Marrow Allografts. / Jones, Monica; Komatsu, Masanobu; Levy, Robert B.

In: Biology of Blood and Marrow Transplantation, Vol. 6, No. 4 A, 01.01.2000, p. 456-464.

Research output: Contribution to journalArticle

@article{38d6890d6ff14d4393ba2da22362d194,
title = "Cytotoxically Impaired Transplant Recipients Can Efficiently Resist Major Histocompatibility Complex-Matched Bone Marrow Allografts",
abstract = "High rates of allograft rejecrion using T cell-depleted marrow or after transplantations into multiply transfused recipients have been reported. Together with current approaches to diminish host preparative immunosuppression before stem cell transplant, issues regarding the cells and effector pathways involved in resistance to progenitor cell presence in recipients are of increasing interest. The present investigation addressed questions concerning the contribution of cytotoxic effector mechanisms used by host cells involved in resistance to progenitor cell engraftment. A murine model was developed in which short-term resistance against major histocompatibility complex (MHC)-matched allogeneic T cell-depleted marrow was examined using a sensitive in vitro assay to detect progenitor cell presence by colony formation in vitro. Resistance was found to be dependent on previous priming to donor non-MHC antigens and could be transferred by a CD3+NK1.1- population. The resistance mechanism explicitly discriminated between donor and syngeneic progenitors after mixed marrow transplantation. Interestingly, the resistance was not impaired in animals unable to mediate cell-mediated cytotoxicity involving perforin-dependent or CD95L-dependent pathways. These results indicate that either cytotoxic effector pathway alone is sufficient to effect marrow allograft resistance or that non-perforin and CD95L effector mechanisms are responsible for barrier activity. The findings are discussed with respect to previous studies concerning T-cell involvement in resistance to MHC-and hematopoietic histoincompatible-mismatched marrow grafts.",
keywords = "CD95L-defective, Cytotoxic impairment, Marrow graft resistance, Minor histocompatibility antigen, Perforin-deficient, T-cell depletion",
author = "Monica Jones and Masanobu Komatsu and Levy, {Robert B.}",
year = "2000",
month = "1",
day = "1",
doi = "10.1016/S1083-8791(00)70038-3",
language = "English (US)",
volume = "6",
pages = "456--464",
journal = "Biology of Blood and Marrow Transplantation",
issn = "1083-8791",
publisher = "Elsevier Inc.",
number = "4 A",

}

TY - JOUR

T1 - Cytotoxically Impaired Transplant Recipients Can Efficiently Resist Major Histocompatibility Complex-Matched Bone Marrow Allografts

AU - Jones, Monica

AU - Komatsu, Masanobu

AU - Levy, Robert B.

PY - 2000/1/1

Y1 - 2000/1/1

N2 - High rates of allograft rejecrion using T cell-depleted marrow or after transplantations into multiply transfused recipients have been reported. Together with current approaches to diminish host preparative immunosuppression before stem cell transplant, issues regarding the cells and effector pathways involved in resistance to progenitor cell presence in recipients are of increasing interest. The present investigation addressed questions concerning the contribution of cytotoxic effector mechanisms used by host cells involved in resistance to progenitor cell engraftment. A murine model was developed in which short-term resistance against major histocompatibility complex (MHC)-matched allogeneic T cell-depleted marrow was examined using a sensitive in vitro assay to detect progenitor cell presence by colony formation in vitro. Resistance was found to be dependent on previous priming to donor non-MHC antigens and could be transferred by a CD3+NK1.1- population. The resistance mechanism explicitly discriminated between donor and syngeneic progenitors after mixed marrow transplantation. Interestingly, the resistance was not impaired in animals unable to mediate cell-mediated cytotoxicity involving perforin-dependent or CD95L-dependent pathways. These results indicate that either cytotoxic effector pathway alone is sufficient to effect marrow allograft resistance or that non-perforin and CD95L effector mechanisms are responsible for barrier activity. The findings are discussed with respect to previous studies concerning T-cell involvement in resistance to MHC-and hematopoietic histoincompatible-mismatched marrow grafts.

AB - High rates of allograft rejecrion using T cell-depleted marrow or after transplantations into multiply transfused recipients have been reported. Together with current approaches to diminish host preparative immunosuppression before stem cell transplant, issues regarding the cells and effector pathways involved in resistance to progenitor cell presence in recipients are of increasing interest. The present investigation addressed questions concerning the contribution of cytotoxic effector mechanisms used by host cells involved in resistance to progenitor cell engraftment. A murine model was developed in which short-term resistance against major histocompatibility complex (MHC)-matched allogeneic T cell-depleted marrow was examined using a sensitive in vitro assay to detect progenitor cell presence by colony formation in vitro. Resistance was found to be dependent on previous priming to donor non-MHC antigens and could be transferred by a CD3+NK1.1- population. The resistance mechanism explicitly discriminated between donor and syngeneic progenitors after mixed marrow transplantation. Interestingly, the resistance was not impaired in animals unable to mediate cell-mediated cytotoxicity involving perforin-dependent or CD95L-dependent pathways. These results indicate that either cytotoxic effector pathway alone is sufficient to effect marrow allograft resistance or that non-perforin and CD95L effector mechanisms are responsible for barrier activity. The findings are discussed with respect to previous studies concerning T-cell involvement in resistance to MHC-and hematopoietic histoincompatible-mismatched marrow grafts.

KW - CD95L-defective

KW - Cytotoxic impairment

KW - Marrow graft resistance

KW - Minor histocompatibility antigen

KW - Perforin-deficient

KW - T-cell depletion

UR - http://www.scopus.com/inward/record.url?scp=0034564268&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034564268&partnerID=8YFLogxK

U2 - 10.1016/S1083-8791(00)70038-3

DO - 10.1016/S1083-8791(00)70038-3

M3 - Article

VL - 6

SP - 456

EP - 464

JO - Biology of Blood and Marrow Transplantation

JF - Biology of Blood and Marrow Transplantation

SN - 1083-8791

IS - 4 A

ER -